Pleura and Peritoneum (Mar 2022)

Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)

  • Sgarbura Olivia,
  • Eveno Clarisse,
  • Alyami Mohammad,
  • Bakrin Naoual,
  • Guiral Delia Cortes,
  • Ceelen Wim,
  • Delgadillo Xavier,
  • Dellinger Thanh,
  • Di Giorgio Andrea,
  • Kefleyesus Amaniel,
  • Khomiakov Vladimir,
  • Mortensen Michael Bau,
  • Murphy Jamie,
  • Pocard Marc,
  • Reymond Marc,
  • Robella Manuela,
  • Rovers Koen P.,
  • So Jimmy,
  • Somashekhar S.P.,
  • Tempfer Clemens,
  • Van der Speeten Kurt,
  • Villeneuve Laurent,
  • Yong Wei Peng,
  • Hübner Martin

DOI
https://doi.org/10.1515/pp-2022-0102
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 7

Abstract

Read online

Safe implementation and thorough evaluation of new treatments require prospective data monitoring and standardization of treatments. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a promising alternative for the treatment of patients with peritoneal disease with an increasing number of suggested drug regimens. The aim was to reach expert consensus on current PIPAC treatment protocols and to define the most important research topics.

Keywords